$37.33
0.35% today
Nasdaq, Sep 16, 08:19 pm CET
ISIN
US45166A1025
Symbol
IDYA
Sector
Industry

IDEAYA Biosciences Inc Stock price

$37.46
-0.72 1.89% 1M
-8.25 18.05% 6M
+1.88 5.28% YTD
+8.28 28.38% 1Y
+11.28 43.09% 3Y
+29.67 380.87% 5Y
+26.27 234.76% 10Y
Nasdaq, Closing price Fri, Sep 13 2024
+1.35 3.74%
ISIN
US45166A1025
Symbol
IDYA
Sector
Industry

Key metrics

Market capitalization $3.16b
Enterprise Value $2.46b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 206.09
P/S ratio (TTM) P/S ratio 264.61
P/B ratio (TTM) P/B ratio 3.06
Revenue growth (TTM) Revenue growth -73.51%
Revenue (TTM) Revenue $11.96m
EBIT (operating result TTM) EBIT $-191.39m
Free Cash Flow (TTM) Free Cash Flow $-134.36m
Cash position $701.66m
EPS (TTM) EPS $-2.18
P/E forward negative
P/S forward 323.55
EV/Sales forward 252.00
Short interest 15.11%
Show more

Is IDEAYA Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

IDEAYA Biosciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a IDEAYA Biosciences Inc forecast:

13x Buy
100%

Analyst Opinions

13 Analysts have issued a IDEAYA Biosciences Inc forecast:

Buy
100%

Financial data from IDEAYA Biosciences Inc

Jun '24
+/-
%
Net Profit -154 -154
107% 107%
-1,285%
Depreciation and Amortization 4.19 4.19
22% 22%
35%
Stock Compensation 26 26
82% 82%
219%
Operating Cash Flow -131 -131
20% 20%
-1,092%
Investments 3.74 3.74
84% 84%
31%
Dividend Paid - -
-
-
Free Cash Flow -134 -134
21% 21%
-1,123%

In millions USD.

Don't miss a Thing! We will send you all news about IDEAYA Biosciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IDEAYA Biosciences Inc Stock News

Neutral
PRNewsWire
17 days ago
SOUTH SAN FRANCISCO, Calif. , Aug. 30, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on August 29, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 34,000 shares of the Comp...
Neutral
PRNewsWire
21 days ago
SOUTH SAN FRANCISCO, Calif. , Aug. 26, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference.
Neutral
PRNewsWire
24 days ago
SOUTH SAN FRANCISCO, Calif. , Aug. 23, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on August 19, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 150,000 shares of the Com...
More IDEAYA Biosciences Inc News

Company Profile

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Head office United States
CEO Yujiro Hata
Employees 124
Founded 2015
Website www.ideayabio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today